
21.01.2020
Genekam has developed novel corona virus 2020 (Wuhan strain specific) kits and potential therapeutic molecules.
21.01.2020
3D Genomemedicine Inc is going to operate in USA
Genekam has developed a number of therapeutic molecules for therapy of Ebola virus, Middle east Syndrome virus and Influenza virus (H1N1)